Corrigendum: Development and validation of a m6A -regulated prognostic signature in lung adenocarcinoma

Yaxin Chen,Lei Xia,Yuxuan Peng,Gang Wang,Liyun Bi,Xue Xiao,Cui Li,Weimin Li

DOI: https://doi.org/10.3389/fonc.2023.1309950

IF: 4.7

2023-11-07

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2022.947808.].

oncology

What problem does this paper attempt to address?

Corrigendum: NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis

Xu-Sheng Liu,Lu-Meng Zhou,Ling-Ling Yuan,Yan Gao,Xue-Yan Kui,Xiao-Yu Liu,Zhi-Jun Pei

DOI: https://doi.org/10.3389/fimmu.2021.751004

IF: 7.3

2021-08-31

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2021.724741.].

immunology
Corrigendum: Immune regulation and prognostic prediction model establishment and validation of PSMB6 in lung adenocarcinoma

Haiyang Zhao,Kexin Luo,Meihan Liu,Yuanze Cai,Siman Liu,Shijuan Li,Yongsheng Zhao,Hongpan Zhang

DOI: https://doi.org/10.3389/fgene.2024.1531321

IF: 3.7

2024-12-04

Frontiers in Genetics

Abstract:This article is a correction to: Immune regulation and prognostic prediction model establishment and validation of PSMB6 in lung adenocarcinoma

genetics & heredity
Corrigendum: Comprehensive analysis of the transcriptome-wide m6A methylome in lung adenocarcinoma by MeRIP sequencing

Wenli Mao,Qingzhen Yu,Kefeng Wang,Qiang Ma,Yuxin Zheng,Guojun Zhang,Wei Luo,Nianwu Wang,Yukun Wang

DOI: https://doi.org/10.3389/fonc.2022.1032295

IF: 4.7

2022-10-04

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2022.791332.].

oncology
Corrigendum: Identification of Microtube-Associated Biomarkers in Diffuse Large B-cell Lymphoma and Prognosis Prediction.

Wenqi Wu,Su Liu,Linyan Tian,Cheng Li,Yanan Jiang,Jinhuan Wang,Yangyang Lv,Jing Guo,Donghui Xing,Yixin Zhai,Huimeng Sun,Yuhang Li,Luying Zhang,Xiang He,Kaiping Luo,Hongjie Zhan,Zhigang Zhao

DOI: https://doi.org/10.3389/fgene.2023.1180076

IF: 3.7

2023-01-01

Frontiers in Genetics

Abstract:[This corrects the article DOI: 10.3389/fgene.2022.1092678.].
Corrigendum: Identification of an autophagy-related 12-lncRNA signature and evaluation of NFYC-AS1 as a pro-cancer factor in lung adenocarcinoma

Fang Tong,Lifa Xu,Sheng Xu,Mingming Zhang

DOI: https://doi.org/10.3389/fgene.2022.1050296

IF: 3.7

2022-10-25

Frontiers in Genetics

Abstract:[This corrects the article DOI: 10.3389/fgene.2022.834935.].

genetics & heredity
Corrigendum to "N6-methyladenosine modified LINC00901 promotes pancreatic cancer progression through IGF2BP2/MYC axis" [Genes & Diseases 10 (2023) 554-567]

Wan-Xin Peng,Fei Liu,Jia-Hong Jiang,Hang Yuan,Ziqiang Zhang,Liu Yang,Yin-Yuan Mo

DOI: https://doi.org/10.1016/j.gendis.2024.101352

2024-06-15

Abstract:[This corrects the article DOI: 10.1016/j.gendis.2022.02.014.].
Corrigendum: The Identification of Two RNA Modification Patterns and Tumor Microenvironment Infiltration Characterization of Lung Adenocarcinoma

Wan He,Gengpeng Lin,Chaohu Pan,Wenwen Li,Jing Shen,Yangli Liu,Hui Li,Dongfang Wu,Xuejia Lin

DOI: https://doi.org/10.3389/fgene.2022.879922

IF: 3.7

2022-03-11

Frontiers in Genetics

Abstract:[This corrects the article DOI: 10.3389/fgene.2022.761681.].

genetics & heredity
Corrigendum: Development and validation of a prognostic nomogram based on DNA methylation-driven genes for patients with ovarian cancer

Min Zhou,Shasha Hong,Bingshu Li,Cheng Liu,Ming Hu,Jie Min,Jianming Tang,Li Hong

DOI: https://doi.org/10.3389/fgene.2022.951409

IF: 3.7

2022-08-15

Frontiers in Genetics

Abstract:[This corrects the article DOI: 10.3389/fgene.2021.675197.].

genetics & heredity
Corrigendum: Clinical Significance and Immunometabolism Landscapes of a Novel Recurrence-Associated Lipid Metabolism Signature In Early-Stage Lung Adenocarcinoma: A Comprehensive Analysis

Mingchuang Zhu,Qingpeng Zeng,Tao Fan,Yuanyuan Lei,Feng Wang,Sufei Zheng,Xinfeng Wang,Hui Zeng,Fengwei Tan,Nan Sun,Qi Xue,Jie He

DOI: https://doi.org/10.3389/fimmu.2022.909105

IF: 7.3

2022-05-04

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2022.783495.].

immunology
Corrigendum to “ARMCX Family Gene Expression Analysis and Potential Prognostic Biomarkers for Prediction of Clinical Outcome in Patients with Gastric Carcinoma”

TingAn Wang,HuaGe Zhong,YuZhou Qin,WeiYuan Wei,Zhao Li,MingWei Huang,XiaoLing Luo

DOI: https://doi.org/10.1155/2021/3179693

2021-02-09

BioMed Research International

Abstract:[This corrects the article DOI: 10.1155/2020/3575038.].

biotechnology & applied microbiology,medicine, research & experimental
Corrigendum: Long non-coding RNA AL139385.1 as a novel prognostic biomarker in lung adenocarcinoma

Xi Chen,Jishu Guo,Fan Zhou,Wenjun Ren,Xiaobin Huang,Jun Pu,Xiaoqun Niu,Xiulin Jiang

DOI: https://doi.org/10.3389/fonc.2024.1223478

IF: 4.7

2024-09-04

Frontiers in Oncology

Abstract:This article is a correction to: Long Non-Coding RNA AL139385.1 as a Novel Prognostic Biomarker in Lung Adenocarcinoma

oncology
Corrigendum: A New Prognostic Risk Score: Based on the Analysis of Autophagy-Related Genes and Renal Cell Carcinoma

Minxin He,Mingrui Li,Yawen Guan,Ziyan Wan,Jie Tian,Fangshi Xu,Haibin Zhou,Mengchun Gao,Hang Bi,Tie Chong

DOI: https://doi.org/10.3389/fgene.2022.904512

IF: 3.7

2022-01-01

Frontiers in Genetics

Abstract:[This corrects the article DOI: 10.3389/fgene.2021.820154.].
Corrigendum: Comprehensive transcriptomic analysis of critical RNA regulation associated with metabolism and prognosis in clear cell renal carcinoma

Si Liu,Honglan Zhou,Gang Wang,Xin Lian

DOI: https://doi.org/10.3389/fcell.2023.1216783

IF: 5.5

2023-06-01

Frontiers in Cell and Developmental Biology

Abstract:[This corrects the article DOI: 10.3389/fcell.2021.709490.].

cell biology,developmental biology
Corrigendum: Identification and validation of immune-related methylation clusters for predicting immune activity and prognosis in breast cancer

Anli Yang,Ying Zhou,Yanan Kong,Xiaoli Wei,Feng Ye,Lijuan Zhang,Xian Zhong,Mingyue Li,Shilin Lu,Xin An,Weikai Xiao

DOI: https://doi.org/10.3389/fimmu.2024.1372991

IF: 7.3

2024-01-31

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2021.704557.].

immunology
Corrigendum: Dissecting the Role of N6-Methylandenosine-Related Long Non-Coding RNAs Signature in Prognosis and Immune Microenvironment of Breast Cancer

Jinguo Zhang,Benjie Shan,Lin Lin,Jie Dong,Qingqing Sun,Qiong Zhou,Jian Chen,Xinghua Han

DOI: https://doi.org/10.3389/fcell.2021.812770

IF: 5.5

2021-12-09

Frontiers in Cell and Developmental Biology

Abstract:[This corrects the article DOI: 10.3389/fcell.2021.711859.].

cell biology,developmental biology
Corrigendum: MXD3 as an Immunological and Prognostic Factor From Pancancer Analysis

Xiaoyu Zhang,Xiaoqin He,Yue Li,Yangtao Xu,Wenliang Chen,Xin Liu,Xinyao Hu,Lin Xiong,Ximing Xu

DOI: https://doi.org/10.3389/fmolb.2021.826905

IF: 6.113

2021-12-22

Frontiers in Molecular Biosciences

Abstract:[This corrects the article DOI: 10.3389/fmolb.2021.702206.].

biochemistry & molecular biology
Corrigendum: The m6A-methylated mRNA pattern and the activation of the Wnt signaling pathway under the hyper-m6A-modifying condition in the keloid

Can-Xiang Lin,Zhi-Jing Chen,Qi-Lin Peng,Ke-Rong Xiang,Du-Qing Xiao,Ruo-Xi Chen,Taixing Cui,Yue-Sheng Huang,Hong-Wei Liu

DOI: https://doi.org/10.3389/fcell.2023.1144733

IF: 5.5

2023-01-31

Frontiers in Cell and Developmental Biology

Abstract:[This corrects the article DOI: 10.3389/fcell.2022.947337.].

cell biology,developmental biology
Corrigendum: Identification of Signature Genes Associated With Invasiveness and the Construction of a Prognostic Model That Predicts the Overall Survival of Bladder Cancer

Yang He,Yongxin Wu,Zhe Liu,Boping Li,Ning Jiang,Peng Xu,Abai Xu

DOI: https://doi.org/10.3389/fgene.2022.880633

IF: 3.7

2022-05-17

Frontiers in Genetics

Abstract:[This corrects the article DOI: 10.3389/fgene.2021.694777.].

genetics & heredity
Corrigendum: Identification of DYNLT1 associated with proliferation, relapse, and metastasis in breast cancer

Sen Miao,Gaoda Ju,Chonghua Jiang,Bing Xue,Lihua Zhao,Rui Zhang,Han Diao,Xingzhou Yu,Linlin Zhang,Xiaozao Pan,Hua Zhang,Lijuan Zang,Lei Wang,Tianhao Zhou

DOI: https://doi.org/10.3389/fmed.2024.1375203

IF: 3.9

2024-02-05

Frontiers in Medicine

Abstract:[This corrects the article DOI: 10.3389/fmed.2023.1167676.].

medicine, general & internal
Corrigendum: Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma

Xiaofan Hu,Mingyang Bao,Jiacheng Huang,Lin Zhou,Shusen Zheng

DOI: https://doi.org/10.3389/fonc.2020.617539

IF: 4.7

2020-01-01

Frontiers in Oncology

Abstract:CORRECTION article Front. Oncol., 20 November 2020Sec. Molecular and Cellular Oncology Volume 10 - 2020 | https://doi.org/10.3389/fonc.2020.617539

Corrigendum: Development and validation of a m6A -regulated prognostic signature in lung adenocarcinoma

Corrigendum: NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis

Corrigendum: Immune regulation and prognostic prediction model establishment and validation of PSMB6 in lung adenocarcinoma

Corrigendum: Comprehensive analysis of the transcriptome-wide m6A methylome in lung adenocarcinoma by MeRIP sequencing

Corrigendum: Identification of Microtube-Associated Biomarkers in Diffuse Large B-cell Lymphoma and Prognosis Prediction.

Corrigendum: Identification of an autophagy-related 12-lncRNA signature and evaluation of NFYC-AS1 as a pro-cancer factor in lung adenocarcinoma

Corrigendum to "N6-methyladenosine modified LINC00901 promotes pancreatic cancer progression through IGF2BP2/MYC axis" [Genes & Diseases 10 (2023) 554-567]

Corrigendum: The Identification of Two RNA Modification Patterns and Tumor Microenvironment Infiltration Characterization of Lung Adenocarcinoma

Corrigendum: Development and validation of a prognostic nomogram based on DNA methylation-driven genes for patients with ovarian cancer

Corrigendum: Clinical Significance and Immunometabolism Landscapes of a Novel Recurrence-Associated Lipid Metabolism Signature In Early-Stage Lung Adenocarcinoma: A Comprehensive Analysis

Corrigendum to “ARMCX Family Gene Expression Analysis and Potential Prognostic Biomarkers for Prediction of Clinical Outcome in Patients with Gastric Carcinoma”

Corrigendum: Long non-coding RNA AL139385.1 as a novel prognostic biomarker in lung adenocarcinoma

Corrigendum: A New Prognostic Risk Score: Based on the Analysis of Autophagy-Related Genes and Renal Cell Carcinoma

Corrigendum: Comprehensive transcriptomic analysis of critical RNA regulation associated with metabolism and prognosis in clear cell renal carcinoma

Corrigendum: Identification and validation of immune-related methylation clusters for predicting immune activity and prognosis in breast cancer

Corrigendum: Dissecting the Role of N6-Methylandenosine-Related Long Non-Coding RNAs Signature in Prognosis and Immune Microenvironment of Breast Cancer

Corrigendum: MXD3 as an Immunological and Prognostic Factor From Pancancer Analysis

Corrigendum: The m6A-methylated mRNA pattern and the activation of the Wnt signaling pathway under the hyper-m6A-modifying condition in the keloid

Corrigendum: Identification of Signature Genes Associated With Invasiveness and the Construction of a Prognostic Model That Predicts the Overall Survival of Bladder Cancer

Corrigendum: Identification of DYNLT1 associated with proliferation, relapse, and metastasis in breast cancer

Corrigendum: Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma